Delivery Order SPE2DB20D2001-SPE2DB23FM43Y
- Not listed
- This federal contract award, valued at $3,134.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of atovaquone-proguanil 250-100 100s, a medication used for the treatment and prevention of malaria. The contract is a Firm Fixed Price Delivery Order with a period of performance extending through May 9, 2025. This award is not designated as a set-aside contract,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,978.95 firm fixed-price delivery order is for the supply of Atovaquone-Proguanil 250-100 100s, a pharmaceutical product used for the prevention and treatment of malaria. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,056.83, is for the delivery of atovaquone-proguanil 250-100 mg tablets, a prescription medication used to prevent and treat malaria. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,302.57 firm fixed-price contract is for the procurement of 4,561,582,391 units of Atovaquone-Proguanil 250-100 100S, a pharmaceutical product used for the prevention and treatment of malaria. The contract is not designated with any set-aside requirements, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,828.86 firm fixed-price delivery order is for the supply of Atovaquone-Proguanil 250-100 100s, a prescription medication used for the prevention and treatment of malaria. The contract has an ultimate completion date of March 10, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,273.48 firm-fixed-price contract is for the supply of Atovaquone-Proguanil 250-100 100s, a pharmaceutical product used for the prevention and treatment of malaria. The contract has a completion date of November 26, 2021. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,590.56 firm fixed-price delivery order is for the supply of Atovaquone-Proguanil 250-100 100s, a medication used for malaria prevention and treatment. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
- This federal contract award, valued at $6,831.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB24D6038|SPE2DB25FELXB) for the supply of Atovaquone-Proguanil 250-100 100s, a medication used for the prevention and treatment of malaria. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $11,348.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Atovaquone-Proguanil 250-100 100S, a medication used for the prevention and treatment of malaria. The contract is not designated as a set-aside and represents an open competition award. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Atovaquone-Proguanil 250-100 100S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price of $6,073.56 and an ultimate completion date of March 10, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB23FM43YDelivery Order
This federal contract award is a delivery order (SPE2DB20D2001|SPE2DB23FM43Y) valued at $9,318.35, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of atovaquone-proguanil 250-100 UD 24s, a pharmaceutical product used to prevent and treat malaria. The contract is a firm fixed-price agreement with a completion date of March 8, 2023. There is no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 3/7/23 |